BioCentury | Jul 28, 2020
Finance

Founded by Dipp and Lum, growth firm Biospring to invest in services, tools, software

Newly launched Biospring Partners hopes to fill what it sees as a gap in the market by making growth investments in tools, services and software companies that can help biopharmas’ R&D become more efficient. Biospring...
BioCentury | Nov 2, 2017
Company News

Management tracks: Melinta, Lundbeck

...John Bluth as EVP of investor relations and corporate communications. Wechsler was operating partner at Welsh, Carson, Anderson & Stowe...
BioCentury | Sep 19, 2011
Financial News

Valeritas completes venture financing

...N.J. Business: Drug delivery, Endocrine/Metabolic Date completed: 9/12/11 Type: Venture financing Raised: $150 million Investors: Welsh, Carson, Anderson & Stowe...
BioCentury | Sep 19, 2011
Company News

Valeritas board of directors update

...Inc. , Bridgewater, N.J. Business: Drug delivery, Endocrine/Metabolic Appointed: Daniel Pelak, senior industry executive at Welsh, Carson, Anderson & Stowe...
BioCentury | Sep 13, 2011
Financial News

Valeritas raises $150M in series C

...company Valeritas Inc. (Bridgewater, N.J.) raised $150 million in a series C round led by Welsh, Carson, Anderson & Stowe...
BioCentury | May 2, 2011
Finance

Oxford bulks up

...Sumitomo Corp. of America (SCOA) and a new shareholder, the IT and healthcare investment firm Welsh, Carson, Anderson & Stowe...
BioCentury | May 2, 2011
Financial News

Oxford Finance Corp. financial update

...Life sciences and healthcare debt provider Oxford Finance raised $460 million from new shareholder Welsh, Carson, Anderson & Stowe and...
BioCentury | Nov 21, 2001
Financial News

MTS raises $110 million for fund

MTS raised $110 million in a first closing for its Healthcare Private Equity Fund, which will invest broadly in healthcare sectors including healthcare information technology, pharmaceuticals and pharma services, medical devices, distribution, acute care, post-acute...
Items per page:
1 - 8 of 8
BioCentury | Jul 28, 2020
Finance

Founded by Dipp and Lum, growth firm Biospring to invest in services, tools, software

Newly launched Biospring Partners hopes to fill what it sees as a gap in the market by making growth investments in tools, services and software companies that can help biopharmas’ R&D become more efficient. Biospring...
BioCentury | Nov 2, 2017
Company News

Management tracks: Melinta, Lundbeck

...John Bluth as EVP of investor relations and corporate communications. Wechsler was operating partner at Welsh, Carson, Anderson & Stowe...
BioCentury | Sep 19, 2011
Financial News

Valeritas completes venture financing

...N.J. Business: Drug delivery, Endocrine/Metabolic Date completed: 9/12/11 Type: Venture financing Raised: $150 million Investors: Welsh, Carson, Anderson & Stowe...
BioCentury | Sep 19, 2011
Company News

Valeritas board of directors update

...Inc. , Bridgewater, N.J. Business: Drug delivery, Endocrine/Metabolic Appointed: Daniel Pelak, senior industry executive at Welsh, Carson, Anderson & Stowe...
BioCentury | Sep 13, 2011
Financial News

Valeritas raises $150M in series C

...company Valeritas Inc. (Bridgewater, N.J.) raised $150 million in a series C round led by Welsh, Carson, Anderson & Stowe...
BioCentury | May 2, 2011
Finance

Oxford bulks up

...Sumitomo Corp. of America (SCOA) and a new shareholder, the IT and healthcare investment firm Welsh, Carson, Anderson & Stowe...
BioCentury | May 2, 2011
Financial News

Oxford Finance Corp. financial update

...Life sciences and healthcare debt provider Oxford Finance raised $460 million from new shareholder Welsh, Carson, Anderson & Stowe and...
BioCentury | Nov 21, 2001
Financial News

MTS raises $110 million for fund

MTS raised $110 million in a first closing for its Healthcare Private Equity Fund, which will invest broadly in healthcare sectors including healthcare information technology, pharmaceuticals and pharma services, medical devices, distribution, acute care, post-acute...
Items per page:
1 - 8 of 8